Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Authors
Keywords
-
Journal
CEPHALALGIA
Volume 38, Issue 10, Pages 1644-1657
Publisher
SAGE Publications
Online
2018-08-25
DOI
10.1177/0333102418796842
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States
- (2018) Machaon Bonafede et al. HEADACHE
- Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
- (2018) Andrew M. Blumenfeld et al. JOURNAL OF HEADACHE AND PAIN
- Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective
- (2018) Richard B. Lipton et al. JOURNAL OF MEDICAL ECONOMICS
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey
- (2016) Andrew Messali et al. HEADACHE
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
- (2016) Gillian D. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
- (2016) I. Aicua-Rapun et al. JOURNAL OF HEADACHE AND PAIN
- Supplement 4: Canadian Guidelines on Parkinson's Disease
- (2014) CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- The cost effectiveness of Botox in Italian patients with chronic migraine
- (2014) M. Ruggeri NEUROLOGICAL SCIENCES
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Migraine: The seventh disabler
- (2013) TJ Steiner et al. CEPHALALGIA
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
- (2013) Anthony J. Batty et al. JOURNAL OF MEDICAL ECONOMICS
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine
- (2012) Patrick J. Gillard et al. VALUE IN HEALTH
- Costs associated with outpatient, emergency room and inpatient care for migraine in the USA
- (2011) Ralph P Insinga et al. CEPHALALGIA
- The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics
- (2011) Krista A Payne et al. CEPHALALGIA
- Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
- (2011) Dawn Buse et al. HEADACHE
- Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS)
- (2011) Michael Stokes et al. HEADACHE
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program
- (2011) Sheena K. Aurora et al. HEADACHE
- Cost Effectiveness of Pharmacotherapy for the Prevention of Migraine
- (2010) Junhua Yu et al. CNS DRUGS
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Employment and Work Impact of Chronic Migraine and Episodic Migraine
- (2010) Walter F. Stewart et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
- (2009) Julie Munakata et al. HEADACHE
- Direct Cost Burden Among Insured US Employees With Migraine
- (2008) Kevin Hawkins et al. HEADACHE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started